The Mysterious Case of GSK’s Nigerian Legal Director


Back in February I researched and wrote about Glaxo’s  Legal Director and Company Secretary, Uchenna Uwechia.

The post, GSK’s Promo Scam & The Gulf Bank of Nigeria, has received a lot of interest, particularly from Nigeria. It’s one of them pieces that the mainstream press are either too afraid to publish or, as the case may be, too lazy to follow the links which led to my findings.

Uchenna Uwechia, GSK Consumer Nigeria Plc’s Legal Director and Company Secretary
Yesterday, for a period of two hours this blog, which is monitored by IP software, showed the following…

During his time at Glaxo Nigeria, where he is still currently employed, he was fingered in an investigation into the Gulf Bank of Nigeria and he, along with other named parties, was arraigned on an amended 21-count charge bordering on fraud and financial malpractices during his tenure at the bank.

The arraignment took place in 2014 when it was alleged that Uwechia, during his employment at the bank (2001 – April 2006) was accused of aiding Prince Adekunle Adeyeba Johnson, the Director of the bank, in converting the landed property to personal use.

The outcome of the 2014 trial has mysteriously disappeared from the Internet.

To add further conspiracy-type theories into the mix, the Judge who was presiding over the 2014 trial, Justice Mohammed Yunusa, has recently been embroiled in his own controversy for allegedly accepting bribes from Rickey Tarfa, Principal Counsel and Head of Nigerian based law firm, Rickey Tarfa & Co.

It’s unknown if Justice Mohammed Yunusa was ever bribed by lawyers representing Uchenna Uwechia back in 2014 but it does seem rather bizarre that the 2014 case against the Gulf Bank of Nigeria employees seems to have mysteriously disappeared.

Furthermore, I find yesterday’s blog activity rather dubious too.

When I published my findings back in February, I also sent them to the DOJ who never responded, unlike the British Serious Fraud Office who wrote back to me, thanked me and told me that my findings had been passed on to the department currently investigating GlaxoSmithKline for crimes committed overseas.

It leaves me wondering if the DOJ will do the same.

I don’t know about you but if I was a major shareholder in GlaxoSmithKline Consumer Nigeria PLC  I’d be asking some serious questions about the safety of my investment.


The thoughts and opinions expressed here are those of the individual contributor(s) alone and do not necessarily reflect the views of

Content on this site, including news, quotes, data and other information, is sourced by from official and public sources and other third party content providers for your personal information only, and is not intended for trading purposes. Content on this site is not appropriate for the purposes of making a decision to carry out a transaction or trade. Nor does it provide any form of advice (investment, tax, legal) amounting to investment advice, or make any recommendations regarding particular financial instruments, investments or products.